For the 40+ year period of 1961 to 2002, health care expenses followed a pretty steady upward trend, thanks to things like the introduction of Medicaid, coverage expansion and occasional price increases.1
But between 2003 and 2007, that rampant growth slowed down considerably, and the impact of the recession was felt from 2008-2013.2 Many Americans lost their health care insurance during this time period or stopped going to the doctor because of the money they had to pay out of pocket. Several drug patents also ran out during this 10-year stretch, so the market began to be flooded with new, cheaper generic drugs.3
Since then, however, spending has creeped back up. The cost of large employers providing insurance to their workforce is projected to increase by 5 percent in 2017, while premium increases for public exchange plans are expected to average about 10 percent.4 Employers report they plan to offset increases by:5
Meanwhile, specialty drugs, such as those developed for cancer, can cost thousands of dollars per month. Last year, spending on specialty drugs increased by 18 percent compared to less than 1 percent for standard prescription drugs.8
Four of the largest health insurance companies believe the way to reduce spending is by consolidating, but the Justice Department isn’t so sure. The Anthem/Cigna and Aetna/Humana merger deals are being heavily scrutinized since they would substantially reduce competition within the industry.9 The question remains whether the big five — which potentially could become the big three — would pocket profits resulting from consolidations or pass those savings on to customers.10
1 Aaron C. Catlin and Cathy A. Cowan. Centers for Medicare & Medicaid Services. Nov. 19, 2015. “History of Health Spending in the United States, 1960-2013.” https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/HistoricalNHEPaper.pdf. Accessed Aug. 26, 2016.
4 David McCann. CFO.com. Aug. 9, 2016. “Specialty Drugs Drive Health Care Cost Trend.” http://ww2.cfo.com/health-benefits/2016/08/specialty-drugs-drive-health-care-cost-trend/. Accessed Aug. 26, 2016.
5 Willis Towers Watson. Aug. 8, 2016. “U.S. employers expect health care costs to increase 5.0% in both 2016 and 2017.” https://www.willistowerswatson.com/en/press/2016/08/us-employers-expect-health-care-costs-to-increase-5-percent. Accessed Sept. 2, 2016.
6 Willis Towers Watson. Dec. 15, 2015. “Employers Take Aim to Curb High Cost of Pharmacy Benefits.” https://www.towerswatson.com/en-US/Press/2015/12/employers-take-aim-to-curb-high-cost-of-pharmacy-benefits. Accessed Sept. 2, 2016.
7 Toni Clarke and Ransdell Pierson. Reuters. Aug. 25, 2016. “Mylan offers discounts on EpiPen amid wave of criticism.” http://www.reuters.com/article/us-mylan-nl-pricing-idUSKCN11017J. Accessed Aug. 26, 2016.
8 Alison Kodjak. NPR. March 14, 2016. “Cancer And Arthritis Drugs Drive Up Spending on Medicines.” http://www.npr.org/sections/health-shots/2016/03/14/470417680/cancer-and-arthritis-drugs-drive-up-spending-on-medicines. Accessed Aug. 17, 2016.
9 Jay Hancock. NPR. Aug. 11, 2016. “In Battle of Health Care Titans, Should Insurers Act Like Wal-Mart?” http://www.npr.org/sections/health-shots/2016/08/11/488891554/should-big-insurance-become-like-walmart-to-lower-health-costs. Accessed Aug. 26, 2016.
Daniel Shub, AIF®, RFC®
Wealth Management Advisor & Founder.